• Info
  • Insider Ownership

Insider Trading & Ownership of Steve E. Krognes

Location
Burlingame, CA
Summary
The estimated net worth of Steve E. Krognes is at least $15,537,757 dollars as of 05 Jan 2026. Steve E. Krognes is the Director of Denali Therapeutics Inc. and owns shares of Denali Therapeutics Inc. (DNLI) stock worth about $13.38M. Steve E. Krognes is the Director of Guardant Health, Inc. and owns shares of Guardant Health, Inc. (GH) stock worth about $2.05M. Steve E. Krognes is the Director of PLIANT THERAPEUTICS, INC. and owns shares of PLIANT THERAPEUTICS, INC. (PLRX) stock worth about $111.3K.
Signature
/s/ John Saia, as attorney-in-fact for Steve Krognes
All Insider Reports
All Insider Reports

Notify me when Steve E. Krognes files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Steve E. Krognes

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
DNLI Denali Therapeutics Inc. Director $13,375,435 03 Jun 2025
GH Guardant Health, Inc. Director $2,050,984 31 Dec 2025
PLRX PLIANT THERAPEUTICS, INC. Director $111,338 05 Jun 2025
GRTS Gritstone bio, Inc. Director 16 Jun 2023

Insider Transactions Reported by Steve E. Krognes:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.